MENU
HALO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Halozyme Therapeutics (HALO) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

HALO is expected to report earnings to fall 7.87% to $1.17 per share on February 25

Halozyme Therapeutics HALO Stock Earnings Reports
Q4'24
Est.
$1.17
Q3'24
Beat
by $0.31
Q2'24
Beat
by $0.15
Q1'24
Beat
by $0.10
Q4'23
Beat
by $0.02
The last earnings report on October 31 showed earnings per share of $1.27, beating the estimate of 95 cents. With 1.45M shares outstanding, the current market capitalization sits at 6.00B.
View a ticker or compare two or three
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12390 El Camino Real
Phone
+1 858 794-8889
Employees
373
Web
https://www.halozyme.com